Fig. 1From: Is immunohistochemistry of BRAF V600E useful as a screening tool and during progression disease of melanoma patients?Grade of immunoreactivity of the BRAF V600E Ventana® VE1 antibody in melanoma samples. a Moderate diffuse and granular cytoplasmic staining graded as 2. b Strong granular cytoplasmic staining graded as 3. c Negative staining graded as 0. d Weak diffuse cytoplasmic background staining graded as 1. (Original magnification: ×20)Back to article page